Partners In Practice Articles
Novel Combination of Cytotoxic Agents Proves Effective as First-Line Treatment for Advanced Pancreatic Cancer
Pancreatic adenocarcinoma is a highly aggressive cancer with poor prognosis. The majority of patients are diagnosed with advanced-stage disease and have limited treatment options. Thus there is a critical need for more effective systemic chemotherapies.